Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02494921
Title LEE011 (Ribociclib) in Combination With Docetaxel Plus Prednisone in mCRPC
Recruitment Completed
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors Rahul Aggarwal
Indications

prostate cancer

Therapies

Docetaxel + Filgrastim + Prednisone + Ribociclib

Age Groups: adult
Covered Countries USA


No variant requirements are available.